TrendSense

Getting Ahead of the Curve: Magnesium

By Dr. A. Elizabeth Sloan | January 2, 2012

The next wave in mineral-mania appears to be magnesium. Magnesium was the fastest-growing mineral supplement in the $2.3 billion mineral category over the past three years, posting sales of $340 million in 2009, according to Nutrition Business Journal. SymphonyIRI reported that magnesium supplement sales were up nearly 25% in 2010 in mass channels excluding Walmart.

The next wave in mineral-mania appears to be magnesium. Magnesium was the fastest-growing mineral supplement in the $2.3 billion mineral category over the past three years, posting sales of $340 million in 2009, according to Nutrition Business Journal. SymphonyIRI reported that magnesium supplement sales were up nearly 25% in 2010 in mass channels excluding Walmart.

According to an Office of Dietary Supplements’ (ODS) Fact Sheet, magnesium is a key element in more than 300 biological functions; it helps maintain normal muscle/nerve function, keeps the heart’s rhythm steady, supports a healthy immune system and keeps bones strong.

Magnesium also helps regulate blood sugar levels, promotes normal blood pressure and is involved in energy metabolism and protein synthesis. There is increasing interest in magnesium in preventing/managing hypertension, cardiovascular disease and diabetes.

According to the Council for Responsible Nutrition’s 2011 Consumer Survey on Dietary Supplements, 8% of supplement users take a magnesium supplement, ranking seventh overall—just after vitamin E and before iron. Among supplement users aged 50+, 12% take a magnesium supplement, ranking ninth, just behind glucosamine. One in 10 (13%) adults are making a strong effort to consume more magnesium, per the 2010 Gallup Study of Nutrient Knowledge and Consumption. 

Fifty million U.S. households have a member trying to manage blood pressure. The estimated annual potential for over-the-counter drugs and dietary supplements is $7.8 billion; 27 million heart problems/stroke (estimated at $4.2 billion), 23 million diabetes ($3.4 billion) and 18 million with other heart problems ($2.8 billion), according to SymphonyIRI’s November 2010 OTC Medication Report.

Globally, magnesium is the third most used ingredient in healthy foods/drinks, according to Innova Market Insights.

Market Potential

According to Sloan Trends’ TrendSense model, magnesium is a strong and stable Level 2 mass market opportunity on par with omega 3s and vitamin D. Medical Counts have slowly accelerated throughout the decade and at this very high level will continue to support a strong market condition for the foreseeable future. The spike in 2006-2007 is likely due to media attention of the World Health Organization’s symposium in 2006 on calcium and magnesium in Baltimore, MD.

Interestingly, the linkages of magnesium to heart and bone health crossed over the Medical Threshold early in the decade. Magnesium/blood pressure is currently flirting with crossing the Medical Threshold and is not far behind.

Magnesium linked to bone, heart and blood pressure has crossed into the Popularization Phase indicating timing is perfect for introducing products in the specialty/health food channel and for very health conscious and condition-specific consumers. Specialty marketers should not have products on the shelf.

According to Natural Standard’s peer-reviewed and medically ranked clinical analyses, clinical evidence is strongest for magnesium’s role in managing pre-eclampsia in pregnancy; reducing irregular heartbeat, risk of type 2 diabetes, hearing loss due to noise and severity of acute asthma; and helping to provide neuroprotection for premature infants.

blog comments powered by Disqus
  • Getting Ahead of the Curve: Kids’ Health

    Getting Ahead of the Curve: Kids’ Health

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, Sloan Trends, Inc.||March 2, 2015
    There are significant opportunities to deliver essential nutrients to children in a range of product types.

  • Getting Ahead of the Curve: Magnesium & Potassium

    Getting Ahead of the Curve: Magnesium & Potassium

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, Sloan Trends, Inc.||December 1, 2014
    These important minerals have a bright future across a range of health categories.

  • Getting Ahead of the Curve: Amino Acids

    Getting Ahead of the Curve: Amino Acids

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, RD, Sloan Trends, Inc.||July 1, 2014
    Following the successful boom of protein and sports nutrition products, amino acids could offer strong market differentiation.

  • Getting Ahead of the Curve: Protein Generation II

    Getting Ahead of the Curve: Protein Generation II

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, Sloan Trends, Inc.||May 1, 2014
    Energy linked to protein has reached mega mass-market status and is among the largest overlooked opportunities for protein.

  • Getting Ahead of the Curve: Turmeric & Curcumin

    Getting Ahead of the Curve: Turmeric & Curcumin

    Dr. A. Elizabeth Sloan & Catherine Adams Hutt, Sloan Trends, Inc.||March 3, 2014
    The timing is perfect to spice up sales with turmeric and its bioactive components: curcumin and other curcuminoids.

  • Getting Ahead of the Curve: Sleep

    Getting Ahead of the Curve: Sleep

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, RD, Sloan Trends, Inc.||December 3, 2013
    Regulatory concerns alongside recent recalls and manufacturing issues will continue to drive the sleep aid market in a more natural direction.

  • Getting Ahead of the Curve: Choline

    Getting Ahead of the Curve: Choline

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, RD||October 1, 2013
    Suffering from lack of awareness among consumers, choline has been effectively sidelined as a nutrient of key importance for no apparent reason.

  • Getting Ahead of the Curve: Hispanics & Health

    Getting Ahead of the Curve: Hispanics & Health

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, RD, Sloan Trends, Inc.||July 1, 2013
    Today’s 52 million U.S. Hispanics represent an enormous, unusually diverse and very fast emerging nutraceutical opportunity.

  • Getting Ahead of the Curve: Nutrition, Eye Health & Vision

    Getting Ahead of the Curve: Nutrition, Eye Health & Vision

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, RD, Sloan Trends, Inc.||May 1, 2013
    The nutritional eye health/vision market is set to explode and it’s already on a roll.

  • Getting Ahead of the Curve: Prebiotics

    Getting Ahead of the Curve: Prebiotics

    Dr. A. Elizabeth Sloan & Dr. Catherine Adams Hutt, RD||March 1, 2013
    Prebiotics are poised to become a mass market opportunity within the next six months.

  • Getting Ahead of the Curve: Gluten-Free

    Dr. A. Elizabeth Sloan||December 5, 2012

  • Staying Ahead of the Curve: Vitamins

    Dr. A. Elizabeth Sloan||November 1, 2012

  • Getting Ahead of the Curve: Digestive Regularity

    Dr. A. Elizabeth Sloan, Sloan Trends||May 1, 2012

  • Getting Ahead of the Curve: Whey Protein

    Dr. A. Elizabeth Sloan||November 1, 2011
    Consumer interest in protein is on fire! According to the “2010 Gallup Study of Nutrient Knowledge and Consumption,” four in 10 consumers are making a strong effort to consume more protein; 55% of those trying to lose weight.

  • Getting Ahead of the Curve: DHA, Omega 3, 6, 9

    Dr. A. Elizabeth Sloan||October 1, 2011
    Fish oil/omega 3s are among the most sought after nutritional ingredients. In 2010, omega 3s became America’s third most popular dietary supplement, behind multi-vitamins and calcium

  • Getting Ahead of the Curve: Childhood Obesity

    Dr. A. Elizabeth Sloan||July 1, 2011
    Childhood obesity is one of the fastest growing, most elusive and virtually untapped health and nutrition opportunities in recent history.

  • Getting Ahead of the Curve: Protein & Weight Loss

    Dr. A. Elizabeth Sloan||June 1, 2011
    While low carb may have been one of the hottest diet fads of all time, it’s high protein that’s long been the winner in the war on weight.

  • Getting Ahead of the Curve: Phytosterols

    Dr. A. Elizabeth Sloan||May 1, 2011
    Cholesterol-lowering remains one of the most sought after nutraceutical solutions. Ninety-Eight million (44%) of U.S. adults over age 20 have total cholesterol levels higher than 200 mg/dL; more than 33 million with levels higher than 240 mg/dL (AHA, 2011).

  • Getting Ahead of the Curve: Blood Pressure & Stroke

    Dr. A. Elizabeth Sloan||April 1, 2011
    With one in three adults already afflicted with high blood pressure (HBP)—and the incidence of stroke increasing in those under age 65 and in children—there will be unprecedented demand for products that help lower/manage blood pressure, improve artery health/circulation, prevent platelet aggregation and help cope with the various “side effects” of HBP (e.g., erectile dysfunction).

  • Getting Ahead of the Curve: Sodium

    Dr. A. Elizabeth Sloan||March 1, 2011
    The 2010 U.S. Dietary Guidelines Committee report, mandatory menu labeling for restaurants, and a new American Stroke Association at the American Heart Association are among the new forces fueling the lower sodium movement.

  • Getting Ahead of the Curve: Satiety

    Dr. A. Elizabeth Sloan||December 1, 2010
    With safety issues and consumer skepticism looming over weight loss pills and metabolism-boosting thermogenic agents—and many waist-watchers, especially Boomers, re-focusing on food-based solutions—super-satiating foods, drinks and natural ingredients have tremendous potential to quickly corner the weight loss market.

  • Getting Ahead of the Curve: Immunity

    Dr. A. Elizabeth Sloan||October 1, 2010
    Immunity is one of the fastest growing—and most elusive—nutraceutical markets. The fear of losing one’s job if they become ill, global mega viruses, e.g., H1N1, an unprecedented intolerance among schools to allow children with even minor ailments to stay in class, and the return of serious infectious diseases, e.g., whooping cough, have heated up the immunity market, way beyond its upcoming seasonal boost.

  • Getting Ahead of the Curve: The Gluten-Free Market

    Dr. A. Elizabeth Sloan||September 1, 2010
    The gluten-free market generated $1.6 billion in 2009 and is projected by the Nielsen Co. to grow 15-25% per year to reach $2.6 billion by 2012. Sales of gluten-free products rose 74% in the U.S. between 2004 and 2009. Sales of gluten-free grocery items hit $1.2 billion in 2009, up nearly 14% in the natural channel and more than 11% in conventional stores (SPINS/NFM, 2010).

  • Getting Ahead of the Curve: Properly Positioning Probiotics

    Dr. A. Elizabeth Sloan||July 1, 2010
    Probiotics represent one of the recent bright spots in the U.S. nutraceuticals industry. In 2006, Danone’s Activia Yogurt netted $128 million in year one sales, followed by another $62 million for Activia Light in 2007 per SymphonyIRI Group.

  • Getting Ahead of the Curve: Energizing Ingredients

    Dr. A. Elizabeth Sloan||June 1, 2010
    It’s time to reinvigorate the energy market with a new generation of multi-functional products and solutions directed at specific interlocking need states, more natural/lower calorie/healthier ingredients and longer-lasting effects.